Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications by Bengt SamuelssonAdvances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications by Bengt Samuelsson

Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications

EditorBengt Samuelsson, Rodolfo Paoletti, Giancarlo Folco

Paperback | December 4, 2010

Pricing and Purchase Info

$260.34 online 
$271.95 list price
Earn 1302 plum® points

In stock online

Ships free on orders over $25

Not available in stores


This volume is the proceedings of the 11th International Conference on Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications, held in Florence, Italy, on June 4-8, 2000, which continues the tradition of covering both basic and clinical aspects of prostaglandin and leukotriene research. At this meeting particular emphasis was given to the potential application of the novel COX-2 inhibitors, the genetics of asthma relating to the production of leukotrienes, and novel cellular networks for the production of leukotrienes and lipoxins. Traditionally, as has been done in past meetings of this series, a considerable amount of new material was presented and discussed this year, with particular attention given to the newest clinical data.
Title:Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical ApplicationsFormat:PaperbackDimensions:226 pages, 9.61 × 6.69 × 0 inPublished:December 4, 2010Publisher:Springer NetherlandsLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9048158818

ISBN - 13:9789048158812

Look for similar items by category:


Table of Contents

Preface. List of Contributors. I: Lipoxygenases and Leukotriene Biosynthesis. 1. Phosphorylation and Activation of 5-Lipoxygenase by P38 Kinase-Activated MAPKAP Kinases; O. Werz, et al. 2. 5-Lipoxygenase and the Nucleus: Where, When, How, and Why?; M. Peters-Golden, T.G. Brock. 3. Calcium Binding Site of 5-Lipoxygenase; T. Hammarberg, et al. 4. Regulation of Cellular 50Lipoxygenase Activity by Glutathione Peroxidases; D. Schumann, et al. 5. Novel Aspects Related to Biosynthesis and Biological Actions of Hepoxilins: Interrelationship with Phospholipid Hydro-Peroxide Glutathione Peroxidase (PHGPx); P. Shankaranarayanan, et al. 6. Transcriptional Regulation of the Human Leukotriene C4 Synthase Promoter; J.-L. Zhao, et al. 7. Localization and Translocation of Enzymes Involved in Leukotriene Biosynthesis; Y. Ide, et al. II: Cyclooxygenases and Prostaglandin Biosynthesis. 8. Regulation of COX-2 Expression in Fibroblasts, Osteoblasts, Mast Cells, and Macrophages; H.R. Herschman, et al. 9. Antimicroinflammatory Lipid Signals from Vascular Cyclooxygenase-2: A Novel Mechanism for NSAID and N-3 PUFA Therapeutic Actions; C.N. Serhan, et al. 10. Substrate Interactions in the Cyclooxygenase-1 Active Site; E.D. Thuresson, et al. 11. Mutation of the Human Prostacyclin Synthase Gene; T. Nakayama, et al. 12. Structure and Function of Two Distinct Types of Prostaglandin D Synthase; Y. Urade, O. Hayaishi. 13. Roles of Prostaglandin F Synthase; K. Watanabe, et al. 14. Differential Effects of Nitric Oxide on Cyclooxygenase 1 and 2 Activities in Cultured Cells; S.-I. Murota, et al. III: Phospholipase A2. 15. On the Functional Diversity of Secreted Phospholipases A2: Cloning of Novel Mammalian and HIV-1 Antiviral Properties; G. Lambeau, et al. 16. Regulation of Cytosolic Phospholipase A2 by Phosphorylation; M.H. Gelb, et al. IV: Cytochrome P450 Archidonate Metabolites. 17. Synthesis and Function of 20-Hydroxyeicosatetraenoic Acid in the Kidney; M.L. Schwartzman, et al. V: Receptors. 18. Altered Bronchodilation and Pulmonary Inflammation in Prostanoid EP2 Receptor Knockout Mice; F. Nantel, et al. 19. Induction of Prostaglandin I2 Receptor in Murine Osteoblastic Cell; K. Yamamoto, et al. 20. BLT2, a Second Leukotriene B4 Receptor; T. Yokomizo, et al. 21. Upregulation of Cysteinyl-Leukotriene 1 Receptor Expression by Interleukin-5 in Human Leukocytes; M. Rola-Pleszczynski, et al. 22. Physiological and Pathophysiological Roles of Prostanoids; Lessons from Receptor-Knockout Mice for Clinical Applications; S. Narumiya. 23. Multiple G-Protein Coupling of Chimeric Prostacyclin/Prostaglandin D2 Receptors; H. Wise, K.B.S. Chow. VI: Eicosanoids and Neuroscience. 24. An Unusual Nicotinic Acetylcholine Receptor Activates the 8-Lipoxygenase Pathway in Aplysia Neurons; S.J. Feinmark, et al. VII: Cardiovascular System. 25. Neutrophil-Endothelial Cell Interaction: A Multidirectional Cross-Talk in Leukotriene Generation; G.C. Folco. 26. Cyclooxygenase in the Lamb Ductus Arteriosus: Developmental Changes and Upregulation; F. Coceani, et al. 27. Co-Localization of Prostacyclin (PGI2)-Synthase and Caveolin-1 in Endothelial Cells Underscores New Roles of PGI2 in Angiogenesis; E. Spisni, et al.VIII: Respiratory System. 28. Leukotriene C4 Synthase Gene Polymorphism in Severe Asthma; A. Sampson, et al. IX: Inflammation. 29. Anti-Inflammatory Levels of Aspirin and Salicylate Inhibit Integrin-Dependent Human Neutrophil Aggregation and PMN Influx in COX2- and NFkB(P105)- Knockout Mice; G. Weissmann, et al. 30. Antipyretic Action of Acetaminophen: Inhibition of the Cyclooxygenase Activity of Endothelial Cells Treated with IL-1; J.A. Oates, et al. 31. Leukotriene-Mediated Alteration of Endothelial Barrier Function; N. Gautam, et al. 32. GI and Cardiovascular Profiles of New NSAIDs: Selective COX-2 Inhibitors and NO-NSAIDs; M.N. Muscará, et al. 33. NO-Releasing NSAIDs Modulate Cytokine Secretion; S. Fiorucci, E. Antonelli. 34. Potent Inhibitory Effects of a NO-NSAID (Flurbiprofen Nitroxybutylester) on Bone Resorption in Vitro and in Vivo; S.H. Ralston, et al. X. Cancer. 35. Lipid Peroxidation and Cyclooxygenase-2 Activity in Human Hepatocellular Carcinoma Cell Lines with and without Multiple Drug Resistance: Correlation with Cell Growth; E. Masini, et al. 36. Pulmonary Prostacyclin Synthase Overexpression Improves Survival Following Butylated Hydroxytoluene Exposure; R.L. Keith, et al. XI: Isoprostanes. 37. Reactive Products of the Isoprostane Pathway: Isoketals and Cyclopentenone A2/J2-Isoprostanes; L.J. Roberts, et al. 38. Increased Isoprostane 8-epi- PGF2A in Statin-Induced Myopathy; H. Sinzinger, et al. Index.